069 — Cedarhurst, New York

069 is a clinical research site located in Cedarhurst, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

069 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 069?

069 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 069 conducted?

069 has 1 clinical trials on record. Their work covers Epilepsy.

Is 069 accredited by Crixeo Health?

069 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 069?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.